New therapeutic approaches to acute myeloid leukemia.

about

Role of Circular RNA DLEU2 in Human Acute Myeloid Leukemia

P2860

Q57469873-F77E7143-4D40-4445-A06A-30EC39D8E9AF

P2860

New therapeutic approaches to acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q38090673

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

New therapeutic approaches to acute myeloid leukemia.

@en

type

Item

label

New therapeutic approaches to acute myeloid leukemia.

@en

prefLabel

New therapeutic approaches to acute myeloid leukemia.

@en

P1476

New therapeutic approaches to acute myeloid leukemia.

@en

P2093

Hideo Uchida

http://www.w3.org/2001/XMLSchema#string

Koiti Inokuchi

http://www.w3.org/2001/XMLSchema#string

Masahiro Kizaki

http://www.w3.org/2001/XMLSchema#string

Michihide Tokuhira

http://www.w3.org/2001/XMLSchema#string

Reiko Watanabe

http://www.w3.org/2001/XMLSchema#string

P2860

Back to the roots: the remarkable RAF oncogene story

Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia.

Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.

FLT3 and its role in the pathogenesis of acute myeloid leukaemia

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation

A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

P304

689-706

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17460441.3.6.689

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23506149

http://www.w3.org/2001/XMLSchema#string

New therapeutic approaches to acute myeloid leukemia.

about

P2860

P2860

New therapeutic approaches to acute myeloid leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698